XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, beginning balance $ 456 $ 777
Changes in estimated fair value 10 (114)
Payments (117) (119)
Other 0 (2)
Fair value, ending balance 349 542
Contingent consideration 349 $ 542
Current liability 130  
Sanofi Pasteur    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, ending balance 262  
Contingent consideration $ 262  
Contingent consideration, measurement input, discount rate 0.115